Effect of the Natural Sweetener Xylitol on Gut Hormone Secretion and Gastric Emptying in Humans: A Pilot Dose-Ranging Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
08 Jan 2021
Historique:
received: 16 12 2020
revised: 29 12 2020
accepted: 31 12 2020
entrez: 12 1 2021
pubmed: 13 1 2021
medline: 13 4 2021
Statut: epublish

Résumé

Sugar consumption is associated with a whole range of negative health effects and should be reduced and the natural sweetener xylitol might be helpful in achieving this goal. The present study was conducted as a randomized, placebo-controlled, double-blind, cross-over trial. Twelve healthy, lean volunteers received intragastric solutions with 7, 17 or 35 g xylitol or tap water on four separate days. We examined effects on: gut hormones, glucose, insulin, glucagon, uric acid, lipid profile, as well as gastric emptying rates, appetite-related sensations and gastrointestinal symptoms. We found: (i) a dose-dependent stimulation of cholecystokinin (CCK), active glucagon-like peptide-1 (aGLP-1), peptide tyrosine tyrosine (PYY)-release, and decelerated gastric emptying rates, (ii) a dose-dependent increase in blood glucose and insulin, (iii) no effect on motilin, glucagon, or glucose-dependent insulinotropic peptide (GIP)-release, (iv) no effect on blood lipids, but a rise in uric acid, and (v) increased bowel sounds as only side effects. In conclusion, low doses of xylitol stimulate the secretion of gut hormones and induce a deceleration in gastric emptying rates. There is no effect on blood lipids and only little effect on plasma glucose and insulin. This combination of properties (low-glycemic sweetener which stimulates satiation hormone release) makes xylitol an attractive candidate for sugar replacement.

Identifiants

pubmed: 33429977
pii: nu13010174
doi: 10.3390/nu13010174
pmc: PMC7828005
pii:
doi:

Substances chimiques

Blood Glucose 0
Dipeptides 0
Gastrointestinal Hormones 0
Insulin 0
Lipids 0
Sweetening Agents 0
tyrosyltyrosine 1050-28-8
Uric Acid 268B43MJ25
Gastric Inhibitory Polypeptide 59392-49-3
Glucagon-Like Peptide 1 89750-14-1
Glucagon 9007-92-5
Cholecystokinin 9011-97-6
Xylitol VCQ006KQ1E

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Références

Scand J Gastroenterol. 1987 Sep;22(7):781-4
pubmed: 3672037
Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G735-9
pubmed: 19221011
Gastroenterology. 1980 Oct;79(4):716-9
pubmed: 7409389
Nutrients. 2019 Nov 09;11(11):
pubmed: 31717525
Am J Physiol Endocrinol Metab. 2016 Jun 1;310(11):E1053-61
pubmed: 27117004
Acta Odontol Scand. 1976;34(6):345-51
pubmed: 1070904
Dig Dis Sci. 1979 Jul;24(7):497-500
pubmed: 456236
Auton Neurosci. 2010 Feb 16;153(1-2):41-6
pubmed: 19674941
Am J Clin Nutr. 1989 Jun;49(6):1228-32
pubmed: 2658536
Clin Investig. 1993 Apr;71(4):290-3
pubmed: 8471815
Int J Vitam Nutr Res Suppl. 1982;22:67-88
pubmed: 6802777
Am J Clin Nutr. 2016 Mar;103(3):730-7
pubmed: 26817505
Nutr Res Rev. 2003 Dec;16(2):163-91
pubmed: 19087388
Acta Pol Pharm. 2017 May;74(3):817-826
pubmed: 29513951
Nephrol Dial Transplant. 2013 Sep;28(9):2221-8
pubmed: 23543594
Acta Odontol Scand. 1976;34(4):217-39
pubmed: 795261
J Clin Endocrinol Metab. 2018 Dec 1;103(12):4409-4418
pubmed: 30053031
Acta Physiol (Oxf). 2011 Apr;201(4):405-11
pubmed: 21392266
Fortschr Med. 1977 Jan 13;95(2):99-102
pubmed: 832837
Diabetes. 2013 Oct;62(10):3307-15
pubmed: 24065788
J Food Sci. 2014 Jul;79(7):H1436-42
pubmed: 24962431
Biochem J. 1982 Dec 1;207(3):381-8
pubmed: 7165698
Clin Chem. 1998 May;44(5):991-1001
pubmed: 9590372
Br J Nutr. 2011 May;105(9):1320-8
pubmed: 21255472
Lipids Health Dis. 2014 Dec 16;13:195
pubmed: 25515398
Int J Clin Pharmacol Ther. 1995 Jun;33(6):360-5
pubmed: 7582389
Gastroenterology. 1993 Jun;104(6):1640-7
pubmed: 8500721
Health Psychol. 2011 Jul;30(4):424-9; discussion 430-1
pubmed: 21574706
Z Ernahrungswiss. 1971 Dec;10(4):394-6
pubmed: 5161177
Int J Obes Relat Metab Disord. 2000 Jan;24(1):38-48
pubmed: 10702749
Food Funct. 2015 Mar;6(3):955-62
pubmed: 25656339
Neurogastroenterol Motil. 2015 Jan;27(1):63-71
pubmed: 25393165
Obes Rev. 2010 Mar;11(3):251-70
pubmed: 20122136
Am J Clin Nutr. 2018 May 1;107(5):707-716
pubmed: 29722834
J Diabetes Res. 2016;2016:8352957
pubmed: 26839899

Auteurs

Anne Christin Meyer-Gerspach (AC)

St. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.
Faculty of Medicine, University of Basel, 4001 Basel, Switzerland.

Jürgen Drewe (J)

Department of Clinical Pharmacology and Toxicology, University Hospital of Basel, 4001 Basel, Switzerland.

Wout Verbeure (W)

Translational Research Center for Gastrointestinal Disorders, Catholic University of Leuven, 3000 Leuven, Belgium.

Carel W le Roux (CWL)

Diabetes Complications Research Centre, Conway Institute University College Dublin, 3444 Dublin, Ireland.

Ludmilla Dellatorre-Teixeira (L)

Diabetes Complications Research Centre, Conway Institute University College Dublin, 3444 Dublin, Ireland.

Jens F Rehfeld (JF)

Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark.

Jens J Holst (JJ)

Department of Biomedical Sciences and Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.

Bolette Hartmann (B)

Department of Biomedical Sciences and Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.

Jan Tack (J)

Translational Research Center for Gastrointestinal Disorders, Catholic University of Leuven, 3000 Leuven, Belgium.

Ralph Peterli (R)

Clarunis, Department of Surgery, St. Claraspital, 4002 Basel, Switzerland.

Christoph Beglinger (C)

St. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.
Faculty of Medicine, University of Basel, 4001 Basel, Switzerland.

Bettina K Wölnerhanssen (BK)

St. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.
Faculty of Medicine, University of Basel, 4001 Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH